Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6801
Virtus SEIX Senior Loan ETF
SEIX
$255M
| $1.09M | ﹤0.01% |
+45,376
| New | +$1.09M |
|
6802
Invesco CurrencyShares Canadian Dollar Trust
FXC
$70.8M
| $1.09M | ﹤0.01% |
15,962
-48,565
| -75% | -$3.4M |
|
6803
Graham Corp
GHM
$1.23B
| $1.09M | ﹤0.01% |
24,402
-8,338
| -25% | -$312K |
|
6804
PUT
Kanzhun
BZ
$7.18B
| $1.08M | ﹤0.01% |
78,600
+58,400
| +289% | +$859K |
|
6805
PUT
Protagonist Therapeutics
PTGX
$10.1B
| $1.08M | ﹤0.01% |
28,100
+16,300
| +138% | +$711K |
|
6806
Invesco BuyBack Achievers ETF
PKW
$1.79B
| $1.08M | ﹤0.01% |
9,411
+1,885
| +25% | +$223K |
|
6807
ProQR Therapeutics
PRQR
$318M
| $1.08M | ﹤0.01% |
408,807
+321,830
| +370% | +$1.02M |
|
|
NGD
6808
CALL
DELISTED
New Gold Inc
NGD
| $1.08M | ﹤0.01% |
436,800
+39,800
| +10% | +$110K |
|
|
SUM
6809
PUT
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $1.08M | ﹤0.01% |
21,400
+9,200
| +75% | +$430K |
|
6810
Annovis Bio
ANVS
$78.4M
| $1.08M | ﹤0.01% |
215,207
+112,515
| +110% | +$814K |
|
|
SHEH
6811
Shell PLC ADRhedged
SHEH
$6.67M
| $1.08M | ﹤0.01% |
+22,690
| New | +$1.11M |
|
6812
Unitil
UTL
$988M
| $1.08M | ﹤0.01% |
19,969
+17,503
| +710% | +$1.02M |
|
6813
First Trust Emerging Markets Small Cap AlphaDEX Fund
FEMS
$255M
| $1.08M | ﹤0.01% |
+28,677
| New | +$1.12M |
|
6814
Royce Quant Small-Cap Quality Value ETF
SQLV
$41.2M
| $1.08M | ﹤0.01% |
25,323
-10,062
| -28% | -$435K |
|
6815
CALL
iShares MSCI Turkey ETF
TUR
$228M
| $1.08M | ﹤0.01% |
30,100
-364,100
| -92% | -$12.8M |
|
6816
PUT
Arvinas
ARVN
$630M
| $1.08M | ﹤0.01% |
56,300
+38,800
| +222% | +$943K |
|
6817
CALL
Camden Property Trust
CPT
$10.9B
| $1.08M | ﹤0.01% |
9,300
-9,200
| -50% | -$1.1M |
|
6818
CALL
MGP Ingredients
MGPI
$388M
| $1.08M | ﹤0.01% |
27,400
+21,900
| +398% | +$1.19M |
|
6819
CALL
Invesco DB US Dollar Index Bearish Fund
UDN
$102M
| $1.08M | ﹤0.01% |
64,500
+19,900
| +45% | +$359K |
|
6820
PUT
Geron
GERN
$1.01B
| $1.08M | ﹤0.01% |
304,400
+41,600
| +16% | +$166K |
|
6821
CALL
indie Semiconductor
INDI
$845M
| $1.08M | ﹤0.01% |
265,900
+34,100
| +15% | +$140K |
|
6822
Holley
HLLY
$376M
| $1.07M | ﹤0.01% |
355,662
-293,399
| -45% | -$822K |
|
6823
CALL
Edgewise Therapeutics
EWTX
$5.03B
| $1.07M | ﹤0.01% |
40,200
-29,800
| -43% | -$949K |
|
6824
Vanguard FTSE Pacific ETF
VPL
$8.44B
| $1.07M | ﹤0.01% |
15,106
+6,897
| +84% | +$515K |
|
6825
PUT
Schwab Short-Term US Treasury ETF
SCHO
$13B
| $1.07M | ﹤0.01% |
44,600
-17,000
| -28% | -$412K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.